In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Non-Hispanic Black patients with breast cancer undergoing neoadjuvant chemotherapy have a lower likelihood of experiencing pathologic complete response compared with non-Hispanic White patients. A new study examines several potential reasons why.

Pursuing Progress, Precision, and Equity in Cancer Care

Vital Signs: Racial Disparities in Breast Cancer Severity — United

Outcomes in breast cancer—does ethnicity matter? - ScienceDirect

BRCA1 – Inherited Cancer Registry (ICARE)

In Breast Cancer Patients, What Accounts for Racial Disparities in

MammaPrint® Index as a predictive biomarker for neoadjuvant

In Breast Cancer Patients, What Accounts for Racial Disparities in Pathologic Complete Response? - Early Breast Cancer

Pathologic Complete Response: Understanding the Subtleties - The

Cancers, Free Full-Text